His primary areas of study are Apoptosis, Cell biology, Immunology, Cancer research and Programmed cell death. His Apoptosis research is multidisciplinary, incorporating perspectives in Cancer cell, Molecular biology and Topoisomerase-II Inhibitor. His Cell biology research includes themes of Cell cycle, Biochemistry and Death-inducing signaling complex.
Immunology and Mutation are frequently intertwined in his study. His work carried out in the field of Cancer research brings together such families of science as Cytotoxic T cell, Leukemia and Ex vivo. His study focuses on the intersection of Programmed cell death and fields such as Heat shock protein with connections in the field of Signal transduction and Protein folding.
Eric Solary mainly focuses on Cancer research, Immunology, Cell biology, Molecular biology and Internal medicine. His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Cytotoxic T cell, Haematopoiesis and Cancer. His studies deal with areas such as Cancer cell and Gene as well as Immunology.
His research integrates issues of Apoptosis, Programmed cell death and Cellular differentiation in his study of Cell biology. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology. In his research, Myelodysplastic syndromes and Pathology is intimately related to Leukemia, which falls under the overarching field of Chronic myelomonocytic leukemia.
His primary areas of investigation include Chronic myelomonocytic leukemia, Internal medicine, Immunology, Cancer research and Oncology. His Chronic myelomonocytic leukemia study incorporates themes from Myeloid, Monocytosis, Monocyte, Leukemia and Flow cytometry. As a part of the same scientific family, he mostly works in the field of Myeloid, focusing on White blood cell and, on occasion, Leukemoid reaction.
His Immunology research incorporates elements of Hematopoietic stem cell transplantation and Cell biology. The various areas that Eric Solary examines in his Cell biology study include Apoptosis, Receptor, Inflammasome and Cellular differentiation. He studied Cancer research and Cancer that intersect with DNA sequencing.
Eric Solary spends much of his time researching Immunology, Chronic myelomonocytic leukemia, Cell biology, Leukemia and Cancer research. He interconnects Clinical trial, Hsp90 inhibitor, Intensive care, Stem cell niche and Graft-versus-host disease in the investigation of issues within Immunology. The Cell biology study combines topics in areas such as Chromatin, microRNA and Cellular differentiation.
His studies deal with areas such as Complex Karyotype, Founder effect, Gene, DNA repair and Familial predisposition as well as Leukemia. His research in Cancer research intersects with topics in CD34, Tyrosine kinase, Drug resistance and Tyrosine-kinase inhibitor. His Signal transduction research incorporates elements of Apoptosis and Kinase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
François Ghiringhelli;Cedric Menard;Pierre Emmanuel Puig;Sylvain Ladoire.
Cancer Immunology, Immunotherapy (2007)
Hsp27 negatively regulates cell death by interacting with cytochrome c
Jean-Marie Bruey;Cécile Ducasse;Philippe Bonniaud;Luigi Ravagnan.
Nature Cell Biology (2000)
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
Pierre Fenaux;Claude Chastang;Sylvie Chevret;Miguel Sanz.
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
François Ghiringhelli;Nicolas Larmonier;Elise Schmitt;Arnaud Parcellier.
European Journal of Immunology (2004)
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
Denis Caillot;Olivier Casasnovas;Alain Bernard;Jean-Francois Couaillier.
Journal of Clinical Oncology (1997)
Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferation
François Ghiringhelli;Pierre E. Puig;Stephan Roux;Arnaud Parcellier.
Journal of Experimental Medicine (2005)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron;Cyril Quivoron;Cyril Quivoron;Lucile Couronné;Lucile Couronné;Lucile Couronné;Véronique Della Valle;Véronique Della Valle;Véronique Della Valle;Cécile K. Lopez;Cécile K. Lopez;Cécile K. Lopez.
Cancer Cell (2011)
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin;Sylvain Ladoire;Grégoire Mignot;Julie Vincent.
Journal of Clinical Investigation (2010)
Induction of a common pathway of apoptosis by staurosporine
Richard Bertrand;Eric Solary;Patrick O'Connor;Kurt W. Kohn.
Experimental Cell Research (1994)
HSP27 inhibits cytochrome c-dependent activation of procaspase-9
Carmen Garrido;Jean‐Marie Bruey;Annie Fromentin;Arlette Hammann.
The FASEB Journal (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: